ANNOUNCEMENT 16 Apr 2021

India has announced financial grants to increase the production of an indigenous COVID-19 vaccine.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha
https://pib.gov.in/PressReleseDetail.aspx?PRID=1712271

Inception date: 16 Apr 2021 | Removal date: open ended

Financial grant

On 16 April 2021, the Ministry of Science and Technology through a Press Release announced financial grants to several companies to increase the production capacity of COVID-19 vaccines.

This includes a grant of approximately INR 65 crore (~ USD 8.72 million)* to Bharat Biotech Limited and Haffkine Biopharmaceutical Corporation Limited each and a grant of an undisclosed amount to Indian Immunologicals Limited. Bharat Biotech Limited is a private limited company while the latter two are public sector enterprises.

The grants are announced under the Mission COVID Suraksha announced by the Indian government in November 2020 to accelerate the development and production of indigenous COVID vaccines.

* INR to USD as of 16 April 2021 - INR 74.51/USD

AFFECTED SECTORS

 

AFFECTED PRODUCTS